Advancing towards accurate phenotyping based on metabolic and fibrosis risk in metabolic-dysfunction associated steatotic liver disease: one step closer to personalized care

被引：0
|
作者：
Munoz-Martinez, Sergio [1 ,2 ]
Jimenez-Masip, Alba [1 ,3 ]
Pericas, Juan M. [1 ,3 ,4 ]
机构：
[1] Vall dHebron Hosp Univ, Liver Unit, Vall dHebron Inst Recerca VHIR, Liver Unit, Pg Vall dHebron 119-129, Barcelona 08035, Spain
[2] Univ Barcelona, Barcelona, Spain
[3] Univ Autonoma Barcelona, Barcelona, Spain
[4] Ctr Invest Biomed Red Enfermedades Hepat & Digest, Madrid, Spain
来源：
HEPATOBILIARY SURGERY AND NUTRITION | 2024年 / 13卷 / 01期
关键词：
Metabolic-dysfunction associated steatotic liver disease (MASLD); advanced fibrosis; type 2 diabetes (T2D); non-invasive tests (NITs); OUTCOMES; NAFLD;
D O I：
10.21037/hbsn-23-563
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：128 / 131
页数：4
相关论文
共 50 条
  • [21] Cardiovascular Risk Reduction in Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic Dysfunction-Associated Steatohepatitis
    Bernhard, Johannes
    Galli, Lukas
    Speidl, Walter S.
    Krychtiuk, Konstantin A.
    CURRENT CARDIOLOGY REPORTS, 2025, 27 (01)
  • [22] GUT MYCOBIOME IN THE SPECTRUM OF METABOLIC-DYSFUNCTION ASSOCIATED STEATOTIC LIVER DISEASE (MASLD): FROM MASH TO HEPATOCELLULAR CARCINOMA
    Alvares-da-Silva, Mario
    Perlin, Cassio
    Keingeski, Melina
    Basso, Bruno
    Medeiros, Juliane
    Borges, Francis
    Uribe-Cruz, Carolina
    HEPATOLOGY, 2024, 80 : S669 - S670
  • [23] Metabolic dysfunction-associated steatotic liver disease as a cardiovascular risk factor
    Platek, Anna E.
    Szymanska, Anna
    CLINICAL AND EXPERIMENTAL HEPATOLOGY, 2023, 9 (03) : 187 - 192
  • [24] Noninvasive Tests to Assess Fibrosis and Disease Severity in Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic-Dysfunction-Associated Steatohepatitis
    Tincopa, Monica A.
    Loomba, Rohit
    SEMINARS IN LIVER DISEASE, 2024, 44 (03) : 287 - 299
  • [25] THE STRUGGLE TO DIAGNOSE METABOLIC-DYSFUNCTION ASSOCIATED STEATOTIC LIVER DISEASE IN CHILDREN: HIGH DISSOCIATION BETWEEN LIVER IMAGING AND BIOCHEMISTRIES
    Beauchamp, Giovanna
    Bril, Fernando
    HORMONE RESEARCH IN PAEDIATRICS, 2024, 97 : 279 - 280
  • [26] Fibroscan-based screening to determine the prevalence and severity of metabolic-dysfunction associated steatotic liver disease in diabetes in a quaternary hospital
    Selvarajah, Janakan
    Fourlanos, Spiros
    Gao, Weilun
    Raj, Ashok
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2024, 39 : 117 - 117
  • [27] Genetic Risk Factors for Metabolic Dysfunction-Associated Steatotic Liver Disease
    Pei, Yiying
    Goh, George Boon-Bee
    GUT AND LIVER, 2025, 19 (01) : 8 - 18
  • [28] GASTROINTESTINAL MALIGNANCY RISK IN METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE
    Nwankwo, Chizoba N.
    Eun, Yong
    Nwankwo, Obinna T.
    Osman, Mohamed K.
    Culpepper-Morgan, Joan A.
    GASTROENTEROLOGY, 2024, 166 (05) : S1474 - S1474
  • [29] Prevalence and Risk Factors of Metabolic Dysfunction-associated Steatotic Liver Disease
    Plaza-Aulestia, Nahia
    Ibarguengoitia-Barrena, Oihane
    Sampedro-Andrada, Blanca
    Juan-Lopez, Cristina San
    Morillo-Montanes, Victoria
    Urionaguena, Irati
    Calvo, Itziar
    Seisdedos, David Montero
    Vega-Alvarez, Lucia
    Llorente, Jose Francisco Garcia
    Revenga, Nuria Vegas
    ARTHRITIS & RHEUMATOLOGY, 2024, 76 : 4669 - 4671
  • [30] Rifaximin on epigenetics and autophagy in animal model of hepatocellular carcinoma secondary to metabolic-dysfunction associated steatotic liver disease
    Michalczuk, Matheus Truccolo
    Longo, Larisse
    Keingeski, Melina Belen
    Basso, Bruno de Souza
    Guerreiro, Gabriel Tayguara Silveira
    Ferrari, Jessica T.
    Vargas, Jose Eduardo
    Oliveira, Claudia P.
    Uribe-Cruz, Carolina
    Cerski, Carlos Thadeu Schmidt
    Filippi-Chiela, Eduardo
    Alvares-da-Silva, Mario Reis
    WORLD JOURNAL OF HEPATOLOGY, 2024, 16 (01) : 75 - 90
12345